Now available SUNITINIB MALATE (generic SUTENT®)

SUNITINIB MALATE (generic SUTENT®) capsules are a kinase inhibitor indicated for:

• treatment of adult patients with gastrointestinal stromal tumor (GIST) after disease progression on or intolerance to imatinib mesylate.
• treatment of adult patients with advanced renal cell carcinoma (RCC).
• adjuvant treatment of adult patients at high risk of recurrent RCC following nephrectomy.
• treatment of progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in adult patients with unresectable locally advanced or metastatic disease.